BioCentury
ARTICLE | Clinical News

Synsorb regulatory update

October 30, 1995 8:00 AM UTC

SYB's Synosorb Pk received Orphan Drug designation from the FDA to treat complications related to Hamburger disease (hemolytic uremic syndrome). The Calgary company is conducting pivotal trials of the...